WALTHAM, Mass. (AP) — WALTHAM, Mass. (AP) — Crescent Biopharma, Inc. (CBIO) on Thursday reported a loss of $24.8 million in its second quarter.

On a per-share basis, the Waltham, Massachusetts-based company said it had a loss of 74 cents.

The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 70 cents per share.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CBIO at https://www.zacks.com/ap/CBIO